calling all speakers

The conference is seeking papers that broadly focus on the following key topics:

  • Sustaining durable, muscle-sparing weight loss over time
  • Expanding indications beyond weight loss through amylin and triple agonists
  • Pricing next-generation oral and injectable obesity therapeutics
  • Aligning with Europe's divergent HTA pathways and JCA requirements
  • Responding to biosimilar entry and the first GLP-1 patent cliff
  • Converting out-of-pocket demand into reimbursed patient access

We are inviting presentations, case studies, and panel contributions on these themes from commercial, market access, and payer leaders across the European obesity therapy market.

be a part of our multi-disciplined agenda...

Join a programme where commercial, payer, and clinical voices share achievements, exchange perspectives, and shape how obesity therapies reach European patients. 

Network with key experts, boost your industry presence, and help define the future of obesity therapy access in Europe.

Network

Network

Connect with industry peers and experts to build valuable relationships. An opportunity to build your professional network in an environment fostering growth and collaboration.

Learn

Learn

Engage with leading tech and businesses in the current landscape. Join industry thought leaders tackling major challenges, and dive into deeper discussions on cutting-edge topics.

Lead Generation

Lead Generation

Discover and connect with key industry players relevant to your business. Generate significant leads and broaden your corporate reach, enhancing your presence in the global market.

Amplify

Amplify

Join an exclusive gathering that draws journalists from top media outlets like Bloomberg, Financial Times, Forbes, and CNN Business. Elevate your message to a global audience.

Quick Proposal

SUBSCRIBE FOR UPDATES

By submitting, you agree to receive email communications from the event organizers, including upcoming promotions and discounted tickets, news, and access to related events.